REAP Financial Group »

Atea Pharmaceuticals shares owned by REAP Financial Group

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by REAP Financial Group from 13F filings

Historical chart of REAP Financial Group investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by REAP Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by REAP Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $538 100 5.38

More positions owned by REAP Financial Group

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (GJAN)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (FFEB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (DSEP)
Dimensional Etf Trust Internatnal Val (DFIV)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
First Tr Exchng Traded Fd Vi Ft Vest Uq Eqt (DOCT)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (FMAY)

View all positions for REAP Financial Group

Top funds holding Atea Pharmaceuticals

FMR
BlackRock
BML Capital Management
Tang Capital Management
Vanguard Group
Vanguard Capital Management
Bain Capital Life Sciences Investors
Two Sigma Investments
State Street Corporation
Geode Capital Management
Acadian Asset Management
Dimensional Fund Advisors
Renaissance Technologies
Morgan Stanley
Charles Schwab Investment Management

View all funds holding Atea Pharmaceuticals